From January 9, 2023 to March 31, 2023, the company has repurchased 12,096,900 shares, representing 0.87% for CNY 100.01 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 CNY | +2.22% | +4.21% | -60.30% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.30% | 595M | |
+27.19% | 5.36B | |
-33.59% | 3.4B | |
-2.97% | 2.9B | |
-24.21% | 2.53B | |
-10.11% | 2.27B | |
+43.66% | 1.84B | |
+46.15% | 1.42B | |
+41.90% | 1.38B | |
-13.92% | 1.37B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.